Pyxis Oncology, Inc. · NASDAQ:PYXS
GordonMD Global Investments LP reported a 16.40% stake in Pyxis Oncology, Inc. (Schedule 13G/A)
Event Oct 1, 2026 · Filed Oct 9, 2026
GordonMD Global Investments LP reported a 16.40% stake in Pyxis Oncology, Inc., 20,441,948 shares, as a passive investor on Oct 1, 2026. Filed Oct 9, 2026 (Schedule 13G/A).
- Stake
- 16.40%
- Shares
- 20,441,948
- Intent
- Passive
- What changed
- Stake changed
- Filed together
- 4 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| GordonMD Global Investments LP | 16.40% | 20,441,948 |
| GordonMD Long Biased Master Fund LP | 16.40% | 20,441,948 |
| GordonMD Long Biased GP LLC | 16.40% | 20,441,948 |
| Craig D. Gordon | 16.40% | 20,441,948 |
Source
Related
- Pyxis Oncology, Inc.
- GordonMD Global Investments LP
- Pyxis Oncology, Inc. shareholders
- Schedule 13G/A · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G/A · GordonMD Global Investments LP · Jul 2, 2026
- Schedule 13G · GordonMD Global Investments LP · Sep 23, 2025
- Schedule 13G · Coastlands Capital LP · Oct 5, 2026
- Form 4 · GordonMD Global Investments LP · Oct 2, 2026
- Schedule 13G · Bvf Partners L P · Jul 10, 2026
- Form 4 · Dupont Jakob · Jul 2, 2026
- Schedule 13G/A · Laurion Capital Management LP · Feb 9, 2026